Long-Term Endothelial Effects of COVID-19 in Obesity
Long-Term Endothelial Effects of COVID-19 in Obesity
批准号:
10583481
负责人:
Naomi Miriam Hamburg
金额:
$67.8万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-15 至 2026-02-28
关键词:
2019-nCoVADAMTSAccelerationAcuteAdverse effectsAgeAgingAutomobile DrivingAutopsyBioinformaticsBiology of AgingBlood VesselsCOVID-19COVID-19 impactCOVID-19 patientCOVID-19 susceptibilityCardiacCardiovascular PhysiologyCardiovascular systemCase/Control StudiesCell AgingCellsCessation of lifeClinicalComplementCoronaryCoronavirusCritical IllnessDevelopmentDiseaseDisease susceptibilityElementsEndothelial CellsEndotheliumEventFibrin fragment DFoundationsFutureGene ExpressionGene Expression ProfilingHeartHumanImageIndividualInflammationInflammatoryInsulin ResistanceInvestigationKidneyLeadLinkLongitudinal, observational studyLungMedical centerMetabolic dysfunctionMetforminMicrovascular DysfunctionMinority EnrollmentMolecularNitric OxideNon obeseObesityObesity associated cardiovascular diseaseOxidative StressParticipantPathway interactionsPatientsPeripheralPhenotypePlasmaPositioning AttributePositron-Emission TomographyPredispositionPreventiveProductionProspective StudiesProteomicsRecombinantsRecoveryResearchResearch PersonnelSARS-CoV-2 infectionSARS-CoV-2 infection historySeverity of illnessSymptomsTherapeuticVascular DiseasesVascular EndotheliumVenousViralVisceralcardiovascular effectsendothelial dysfunctionethnic differenceethnic minority populationexperiencegene complementationhigh body mass indexhigh risk populationinsightmolecular phenotypemultidisciplinaryobese patientsobese personpersistent symptompost SARS-CoV-2 infectionprospectivepublic health relevanceracial differenceracial minority populationresponsesenescencesevere COVID-19sextargeted treatmentthromboticvascular bedvon Willebrand Factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Coronavirus 2019 (COVID-19) has infected more than 29 million globally. While the majority of individuals
experience mild symptoms, the presence of obesity among other factors identifies a particularly high-risk group
of individuals for development of severe COVID-19. Severe COVID-19 is characterized by exuberant
inflammation and vascular dysfunction, but long-term cardiovascular effects remain unclear. We hypothesize
that COVID-19 infection has widespread and long-lasting deleterious effects on endothelial function, including
molecular pathways of cellular senescence and inflammation among obese individuals. We propose to
prospectively study 100 obese and non-obese individuals with history of COVID-19 infection and 50 age- and
sex-matched controls. To gain further insights into underlying mechanisms of vascular dysfunction, we will
pursue three related lines of investigation: In Aim 1, we will study the effect of COVID-19 across vascular beds
including peripheral and coronary microvascular function. In Aim 2, we will investigate the association of
COVID-19 and molecular pathways of endothelial activation and senescence using circulating proteomic
profiling, gene expression profiling of freshly isolated human endothelial cells, complemented by interrogation
of targeted endothelial pathways. In Aim 3, we will conduct a prospective longitudinal observational study to
examine the effect of COVID-19 on trajectories of peripheral and coronary microvascular function and
endothelial phenotype over the course of 6 months. This proposal leverages a unique and highly experienced
multidisciplinary team of investigators with expertise in obesity-related cardiovascular disease, endothelial and
aging biology, coronary microvascular dysfunction, and bioinformatics. Importantly, our investigative team has
a track record of successfully enrolling minority participants across two medical centers. With a
disproportionate burden of severe COVID-19 among racial and ethnic minority groups, we will be uniquely
positioned to examine race/ethnic differences in exploratory analyses. These studies have the potential to
provide important insights into mechanisms driving endothelial inflammation and cardiovascular consequences
of COVID-19 among obese individuals and will lay the foundation for future studies focused on long-term
cardiovascular complications and therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease
-
批准号:10681949
-
项目类别:
-
资助金额:$75.29万
-
财政年份:2023
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Long-Term Endothelial Effects of COVID-19 in Obesity
-
批准号:10387464
-
项目类别:
-
资助金额:$73.11万
-
财政年份:2022
-
负责人:Naomi Miriam Hamburg
-
依托单位:
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM
-
批准号:8627636
-
项目类别:
-
资助金额:$54.57万
-
财政年份:2014
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity
-
批准号:9114637
-
项目类别:
-
资助金额:$56.49万
-
财政年份:2013
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity
-
批准号:8708197
-
项目类别:
-
资助金额:$55.36万
-
财政年份:2013
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity
-
批准号:9327027
-
项目类别:
-
资助金额:$56.49万
-
财政年份:2013
-
负责人:Naomi Miriam Hamburg
-
依托单位:
MicroRNA Profile in Peripheral Artery Disease
-
批准号:8301065
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2012
-
负责人:Naomi Miriam Hamburg
-
依托单位:
MicroRNA Profile in Peripheral Artery Disease
-
批准号:8448106
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2012
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Endothelial Insulin Resistance, Inflammation and Vascular Function in Diabetes
-
批准号:7863921
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2010
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Endothelial Insulin Resistance, Inflammation and Vascular Function in Diabetes
-
批准号:8627199
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2010
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Endothelial Insulin Resistance, Inflammation and Vascular Function in Diabetes
-
批准号:8063610
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2010
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Endothelial Insulin Resistance, Inflammation and Vascular Function in Diabetes
-
批准号:8233517
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2010
-
负责人:Naomi Miriam Hamburg
-
依托单位:
Endothelial Insulin Resistance, Inflammation and Vascular Function in Diabetes
-
批准号:8453433
-
项目类别:
-
资助金额:$38.57万
-
财政年份:2010
-
负责人:Naomi Miriam Hamburg
-
依托单位:
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM
-
批准号:8817305
-
项目类别:
-
资助金额:$54.82万
-
财政年份:--
-
负责人:Naomi Miriam Hamburg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
ADAMTS1靶向MDM2/RBM15/hnRNPC/p16轴诱导心脏衰老的作用机制研究
-
批准号:2026JJ81629
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋路平
-
依托单位:
肠道菌群色氨酸代谢产物IPA通过NSUN5/ADAMTS-1途径调控胶原降解抑制肺纤维化
-
批准号:2026JJ81748
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺兼斌
-
依托单位:
TGF-β1/SMAD2调节ADAMTS1抑制HDAC6介导心肌梗死后心肌纤维化的机制研究
-
批准号:2025JJ80555
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈春
-
依托单位:
磁共振/NIR荧光双模态探针的构建及对ADAMTS1介导心肌梗死后心肌纤维化的可视化及定量评估研究
-
批准号:2025JJ80588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:周俊杰
-
依托单位:
基于ADAMTS7启动子区基因多态性探讨
USF1/ADAMTS7通路在动脉粥样硬化易损
斑块中的作用及分子调控机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈林发
-
依托单位:
ADAMTS19介导P65泛素化抑制胃癌血管生
成的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:江英铭
-
依托单位:
ADAMTS4调控AKT1-S473去磷酸化激活线粒体凋亡加重脓毒症心肌病的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:汤晓燕
-
依托单位:
ADAMTS5通过RasGRP1/CHI3L1通路调节胃癌血管生成、侵袭迁移、重塑免疫微环境的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:黄进团
-
依托单位:
Lnc RNA ADAMTS9-AS2/EZH2调控ENO1剪接模式影响膀胱癌细胞糖酵解活性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: